Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg, a drug for treating Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) in India. As the only drug approved in the country for these liver disorders, Saroglitazar Magnesium is poised to play a crucial role […]
In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and Lupin Limited, a leading global pharma entity, have officially declared their collaboration. The two companies have established a licensing and supply agreement for the co-marketing of Saroglitazar Mg, a pivotal medication for the management of Non-Alcoholic Fatty […]
Zydus Lifesciences, an Indian life sciences company, has announced the commencement of Phase IV Real World Data Registry trial “EVIDENCES-XI” for Saroglitazar Magnesium (Mg) in patients with non-alcoholic fatty liver disease (NAFLD) and comorbidities. This late-stage trial aims to evaluate the efficacy of Saroglitazar Mg in approximately 1,500 male and female NAFLD patients, each with […]